Cardiac Rhythm Management Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Cardiac Monitoring and Cardiac Rhythm Management Devices Market Trends and the market is segmented by Product (Defibrillators (Implantable Cardioverter Defibrillators (ICDS) and External Defibrillators (ED)), Pacemakers (Implantable Pacemakers (ICPS) and External Pacemakers), and Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy Defibrillators (CRT-D) and Cardiac Resynchronization Therapy Pacemakers (CRT-P))), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Cardiac Rhythm Management Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Cardiac Rhythm Management Devices Industry Overview

The cardiac rhythm management devices market is highly competitive and consists of a few major players. Companies like Abbott, Abiomed, Biotronik SE & Co KG, Boston Scientific Corporation, Koninklijke Philips NV, LivaNova Plc, Medtronic PPLC, SchillerAG, Shenzhen Mindray Biomedical Electronics Co. Ltd, Physio-Control, Inc. (Stryker), LivaNova Plc, Progetti Srl, and Zoll Medical Corporation, among others, hold the substantial market share in the cardiac rhythm management devices market.

Cardiac Rhythm Management Devices Market Leaders

  1. Abbott

  2. Biotronik SE & Co KG

  3. Boston Scientific Corporation

  4. Medtronic PLC

  5. Koninklijke Philips NV

  6. *Disclaimer: Major Players sorted in no particular order
Cardiac Rhythm Management Devices Market Concentration